Postmenopausal steroid replacement with micronized dehydroepiandrosterone: Preliminary oral bioavailability and dose proportionality studies

American Journal of Obstetrics and Gynecology

Volumn 166, Issue 4, 1992, Pages 1163-1170

  Abraham, Guy E ^a   Casson, Peter R ^a   Dale, Debra ^a   Umstot, Edward S ^a  

^a NONE

Author keywords

Dehydroepiandrosterone; menopause; micronized dehydroepiandrosterone; replacement

Indexed keywords

PLACEBO; PRASTERONE;

ADULT; BIOAVAILABILITY; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HORMONE SUBSTITUTION; HUMAN; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 0026604187     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(11)90602-4     Document Type: Article

References (37)

1. Adrenal and gonadal androgen secretion in normal females
2. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood
3. Decreased adrenal androgen sensitivity to ACTH during aging
4. Evidence for an influence of the ovary on circulating dehydro-epiandrosterone sulfate levels
5. Marked attenuation of ultradian and circadian rhythms of dehydroepiandrosterone in postmenopausal women: evidence for a reduced 17,20-desmolase enzymatic activity
6. Modulation of growth, differentiation and carcinogenesis by dehydroepiandrosterone
7. Inhibition of tumor development by dehydroepiandrosterone and related steroids
8. The influence of subsequent dehydroepiandrosterone, diaminopropane, phenobarbital, butylated hydroxyanisole and butylated hydroxytoluene treatment on the development of preneoplastic and neoplastic lesions in the rat initiated with di-hydroxy-di-n-propyl nitrosamine
9. Metabolic consequences of dehydroepiandrosterone in lean and obese adult Zucker rats
10. Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice
11. Age, steroids and bone mineral content
12. Persistence of increased bone resorption and possible role of dehydroepiandrosterone as a bone metabolism determinant in osteoporotic women in late post-menopause
13. Declining adrenal androgens: an association with bone loss in aging women
14. Prevention of autoantibody formation and prolonged survival in New Zealand black/New Zealand white Fi mice fed dehydroepiandrosterone
15. Inhibition of proteinuria development in aging Sprague-Dawley rats and C57BL/6 mice by long-term treatment with dehydroepiandrosterone
16. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease
17. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men
18. The role of extraglandular estrogen in women in health and disease
19. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women
20. Androgen parameters and their correlation with body weight in one hundred thirty-eight women thought to have hyperandrogenism
21. Plasma steroids in hirsutism
22. Failure of dehydroepiandrosterone to influence energy and protein metabolism in humans
23. Lack of effect of dehydroepiandrosterone in obese men
24. Increasing oral bioavailability of progesterone by formulation
25. Fat-soluble 17 beta-estradiol: a way of reducing dosage in steroid hormonal substitution?
26. The fetal adrenal gland
27. Steroid production by the definitive and fetal zones of the human fetal adrenal gland
28. Isolation and characterization of three forms of joining peptide from adult human pituitaries: lack of adrenal androgen-stim-ulating activity
29. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women
30. Stimulation of androgen-dependent gene expression by the adrenal precursors dehydroepiandrosterone and androstenedione in the rat ventral prostate
31. Growth-stimulating effect of adrenal androgens on the R3327 Dunning prostatic carcinoma
32. Mechanism of inhibition of growth of 3T3-L1 fibroblasts and their differentiation to adipocytes by dehydroepiandrosterone and related steroids: role of glucose-6-phosphate dehydroen-ase
33. Protection against acute lethal viral infections with the native steroid dehydroepiandrosterone (DHEA)
34. Steroid sulphates inhibit the rat hepatic microsomal glucose-6-phosphatase system
35. Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells
36. Inhibition of rabbit lung glucose-6-phosphate dehydrogenase by dehydroepiandrosterone augments oxidant injury
37. Antiglucocorticoid actions of dehydroepiandrosterone and low concentrations in Alzheimer's disease